French company developing TempoTouch, a probe and reagent capsule system that tells surgeons during an operation whether the edges of removed tissue still carry cancer cells. First targets are lung, head and neck, and skin cancers.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.